Lupus Clinical Trials in Los Angeles

Showing 81-100 of 104 trials

Safety Study of AMG 557 in Subjects With Lupus Arthritis

NCT01683695

This is a multicenter, randomized, double-blind, parallel, placebo-controlled, multiple dose study that will enroll approximately 40 systemic lupus erythematosus subjects with active lupus arthritis.

Lupus Arthritis, Systemic Lupus Erythematosus

Amgen20 participantsStarted Jun 2012

Los Angeles, California, United States • San Leandro, California, United States • Danbury, Connecticut, United States +10 more locations

COMPLETEDPHASE2< 1 mile

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

NCT01597050

The purpose of this study is to determine the safety, efficacy and tolerability of topical R333 ointment in Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) patients with active discoid lesions.

Lupus Erythematosus, DiscoidLupus Erythematosus, Systemic

Rigel Pharmaceuticals54 participantsStarted Aug 2012

Los Angeles, California, United States • Redwood City, California, United States • South Bend, Indiana, United States +12 more locations

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Lupus Trials in Other Cities

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Health-related Quality of Life Measure in Pediatric Lupus

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Study of Epratuzumab in Systemic Lupus Erythematosus

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work Disorder

Safety and Efficacy of Ramelteon in Healthy Subjects

Non-Pharmacological Interventions on Sleep in Post-Acute Rehabilitation

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

Functional MRI in Lupus Nephritis

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor

Reiterative Development and Evaluation Study of OSA Therapy System

Etanercept for the Treatment of Lupus Nephritis

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Other Conditions in Los Angeles